
NanoGroup S.A.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients. Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups. NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-29 18:14 |
Quarterly Report
Skonsolidowany Raport 1Q2025
|
Polish | 6.5 MB | |
2025-05-29 17:50 |
Quarterly Report
Skonsolidowany raport za 1Q 2025
|
Polish | 6.5 MB | |
2025-05-26 10:37 |
Declaration of Voting Results & Voting Rights Announcements
Formluarz glosu przez pełnomocnika
|
Polish | 88.5 KB | |
2025-05-26 10:37 |
Proxy Solicitation & Information Statements
pełnomocnistwo os. prawna
|
Polish | 51.2 KB | |
2025-05-26 10:37 |
Declaration of Voting Results & Voting Rights Announcements
Pełnomocnistwo os. fizyczna
|
Polish | 48.8 KB | |
2025-05-26 10:37 |
Declaration of Voting Results & Voting Rights Announcements
Projekty uchwał
|
Polish | 92.4 KB | |
2025-05-26 10:37 |
General Meeting Notice
Ogłoszenie o zwołaniu
|
Polish | 127.9 KB | |
2025-05-26 10:37 |
General Meeting Notice
Ogłoszenie o zwołaniu Walnego Zgromadzenia NanoGroup S.A. - Content (PL)
|
Polish | 14.9 KB | |
2025-05-19 15:48 |
Regulatory News Service
Wybór firmy audytorskiej do przeprowadzania przeglądu i badania sprawozdań fina…
|
Polish | 1.6 KB | |
2025-05-17 18:11 |
Remuneration Report
Opinia biegłego rewidenta
|
Polish | 914.7 KB | |
2025-05-17 18:11 |
Regulatory News Service
Opinia biegłego rewidenta
|
Polish | 914.7 KB | |
2025-05-17 18:11 |
Remuneration Report
Uchwała wraz ze sprawozdaniem
|
Polish | 887.1 KB | |
2025-05-17 18:11 |
Regulatory News Service
Uchwała wraz ze sprawozdaniem
|
Polish | 887.1 KB | |
2025-05-17 18:11 |
Remuneration Report
Sprawozdanie o wynagrodzeniach Członków Zarządu i Rady Nadzorczej za rok 2024 -…
|
Polish | 655 bytes | |
2025-05-17 18:11 |
Remuneration Report
Sprawozdanie o wynagrodzeniach Członków Zarządu i Rady Nadzorczej za rok 2024
|
Polish | 611 bytes |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |